Barinthus Biotherapeutics (BRNS) Live Share Price, Invest From India

Barinthus Biotherapeutics Stock Performance

as on September 9, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.64
Day's Price Range
$0.77
$0.74
13.51%
Downside
4.05%
Upside
52 Week's Low
52 Week's High
$0.51
52-Week Price Range
$1.83
$0.74
30.81%
Downside
147.30%
Upside

Barinthus Biotherapeutics share price movements today

Previous Close: $0.76
Open: $0.75
Volume: 2.7M
Market Cap: $30.2M
Day's Low - High: $0.64 - $0.77
52 Week Low - High: $0.51 - $1.83

Barinthus Biotherapeutics Historical Returns

1 Month Return: + 31.67 %
3 Month Return: + 6.7 %
1 Year Return: -32.72 %
3 Year Return: 0 %
5 Year Return: 0 %

Barinthus Biotherapeutics Stock Fundamentals & Key Indicators

Check Barinthus Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.2M

EPS (TTM)

-1.03

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.74

Industry PE ratio

-1.62

PEG Ratio

-0.01

EBITDA

-37.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-59.18%

Barinthus Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Barinthus Biotherapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Barinthus Biotherapeutics	Buy	$30.2M	NA	-0.74	0.00%	0.00%
Revolution Medicines	StrongBuy	$40.4B	546.52%	-21.30	0.00%	0.00%
Vertex Pharmaceuticals	StrongBuy	$134.2B	192.00%	30.58	86.04%	0.00%
Moderna	Neutral	$85.5B	-35.47%	-26.84	-12.57%	0.00%
Regeneron	Buy	$83.7B	27.94%	19.42	84.86%	0.45%

Stock Returns calculator for Barinthus Biotherapeutics Stock including INR - Dollar returns

The Barinthus Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Barinthus Biotherapeutics investment value today

Current value as on today

₹71,957

Returns

-₹28,043

(-28.04%)

Returns from Barinthus Biotherapeutics Stock

-₹32,727 (-32.73%)

Dollar Impact

₹4,685 (+4.68%)

Analyst Recommendation on Barinthus Biotherapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Barinthus Biotherapeutics. Average target price of $6

Barinthus Biotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Barinthus Biotherapeutics.

What analysts predicted

87.67%UPSIDE

Target Price

Current Price

$0.74

Analyzed by

2 Analysts

High

Target

$6.00

Low

Barinthus Biotherapeutics target price $6, a slight upside of 87.67% compared to current price of $0.74. According to 2 analysts rating.

Indian Investors' Interest in Barinthus Biotherapeutics Stock

Search interest for Barinthus Biotherapeutics Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 1, 2026 to October 31, 2026

Change:47% versus previous 30 day period

Barinthus Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2025	Jun 2025	Sep 2025	Sep 2025	Dec 2025	Dec 2025	Mar 2026	Mar 2026	Jun 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	0	0	0	0	-	-
Operating Income	-23	-23	-15	-15	-9	-9	-9	-9	-11	-11
EBITDA	-19	-19	-13	-13	-10	-10	-4	-4	-8	-8
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	2	2	1	1	0	0	0	0	1	1
Income Before Tax	-21	-21	-14	-14	-11	-11	-5	-5	-10	-10
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-21	-21	-14	-14	-11	-11	-5	-5	-10	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Barinthus Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2021	Dec 2022	Dec 2022	Dec 2023	Dec 2023	Dec 2024	Dec 2024	Dec 2025	Dec 2025
Total Revenue	0	0	44	44	0	0	14	14	-	-
Gross Profit	0	0	44	44	0	0	14	14	-5	-5
Operating Income	-45	-45	-4	-4	-83	-83	-67	-67	-54	-54
EBITDA	-47	-47	5	5	-71	-71	-55	-55	-62	-62
Interest Expense	2	2	0	0	0	0	0	0	0	0
Depreciation	0	0	4	4	5	5	5	5	5	5
Income Before Tax	-51	-51	0	0	-76	-76	-61	-61	-68	-68
Income Tax Expense	0	0	-4	-4	-3	-3	0	0	-2	-2
Net Income	-50	-50	5	5	-73	-73	-61	-61	-66	-66
Net Profit Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	0.00%	0.00%

Barinthus Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2025	Jun 2025	Sep 2025	Sep 2025	Dec 2025	Dec 2025	Mar 2026	Mar 2026	Jun 2026	Jun 2026
Net Income	-21	-21	-14	-14	-11	-11	-5	-5	-10	-10
Operating Cash Flow	-18	-18	-10	-10	-4	-4	-3	-3	-8	-8
Investing Cash Flow	0	0	0	0	0	0	0	0	0	0
Financing Cash Flow	-	-	-	-	-	-	-	-	-	-
Change in Cash	-12	-12	-12	-12	-3	-3	-4	-4	-7	-7

Barinthus Biotherapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2021	Dec 2022	Dec 2022	Dec 2023	Dec 2023	Dec 2024	Dec 2024	Dec 2025	Dec 2025
Net Income	-51	-51	5	5	-73	-73	-61	-61	-66	-66
Operating Cash Flow	-32	-32	-14	-14	-50	-50	-28	-28	-47	-47
Investing Cash Flow	-12	-12	-5	-5	-5	-5	0	0	0	0
Financing Cash Flow	222	222	0	0	1	1	2	2	0	0
Change in Cash	170	170	-19	-19	-52	-52	-29	-29	-40	-40

Global Institutional Holdings in Barinthus Biotherapeutics

Check out the Institutions with significant holdings in Barinthus Biotherapeutics.

Funds	Holdings
GLR Partners, LLC	3.04%
HSG Holding Ltd	3.48%
Citadel Advisors Llc	0.29%
Baird Financial Group, Inc.	0.26%
Millennium Management LLC	0.00%

See all

Insights on Barinthus Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, BRNS stock has moved up by 31.7%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 457.8% return, outperforming this stock by 490.5%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 26.0% return, outperforming this stock by 85.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -5.52M → -10.57M (in $), with an average decrease of 91.6% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 14.96M → -9.17M (in $), with an average decrease of 161.3% per quarter

About Barinthus Biotherapeutics

Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops VTP-1000, an antigen-specific immune tolerance candidate, which is in Phase I clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease; and VTP-300, an immunotherapy, which is in Phase II clinical trial for the treatment of chronic hepatitis B virus infection. It has a license agreement with Oxford University Innovation for the development and commercialization of products with thermo-responsive adjuvant scaffolds; and U.S. National Institutes of Health for the evaluation of synthetic and polymer-based vaccine technology to prevent infectious disease and treat cancer in animal models. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is based in Germantown, Maryland.

Organisation	Barinthus Biotherapeutics
Headquarters	20400 Century Boulevard, Germantown, MD, United States, 20874
Industry	Biotechnology
CEO	Mr. William James Enright MBA

Key Management of Barinthus Biotherapeutics

Name	Title
Mr. Douglas J. Swirsky CFA, CPA	CFO & Principal Accounting Officer
Mr. William James Enright MBA	CEO & Director
Dr. Leon Hooftman M.D.	Chief Medical Officer

FAQs

What is Barinthus Biotherapeutics share price today?

Barinthus Biotherapeutics share price today is $0.74 as on September 9, 2026 at 8:45 am IST at the close of the market. Barinthus Biotherapeutics share today touched a day high of $0.77 and a low of $0.64.

What is the 52 week high and 52 week low for Barinthus Biotherapeutics share?

Barinthus Biotherapeutics share touched a 52 week high of $1.83 on October 7, 2025 and a 52 week low of $0.51 on March 24, 2026. Barinthus Biotherapeutics stock price today i.e. September 9, 2026 at 8:45 am IST is closed at $0.74,which is 59.56% down from its 52 week high and 44.53% up from its 52 week low.

What is Barinthus Biotherapeutics's market capitalisation today?

Barinthus Biotherapeutics market capitalisation is $0.00T as on September 9, 2026 at 8:45 am IST.

How to invest in Barinthus Biotherapeutics Stock (BRNS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Barinthus Biotherapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Barinthus Biotherapeutics Stock (BRNS) from India?

Indian investors can start investing in Barinthus Biotherapeutics (BRNS) shares with as little as ₹94.94999694824219 or $1 (as of October 31, 2026 at 8:15 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Barinthus Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on October 31, 2026 at 8:15 pm IST). Based on Barinthus Biotherapeutics share’s latest price of $0.74 as on September 9, 2026 at 8:45 am IST, you will get 13.5135 shares of Barinthus Biotherapeutics. Learn more about fractional shares .